317 related articles for article (PubMed ID: 34572574)
1. Evaluation of Immune Dysregulation in an Austrian Patient Cohort Suffering from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Lutz L; Rohrhofer J; Zehetmayer S; Stingl M; Untersmayr E
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572574
[TBL] [Abstract][Full Text] [Related]
2. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Cliff JM; King EC; Lee JS; Sepúlveda N; Wolf AS; Kingdon C; Bowman E; Dockrell HM; Nacul L; Lacerda E; Riley EM
Front Immunol; 2019; 10():796. PubMed ID: 31057538
[TBL] [Abstract][Full Text] [Related]
3. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome.
Nagy-Szakal D; Williams BL; Mishra N; Che X; Lee B; Bateman L; Klimas NG; Komaroff AL; Levine S; Montoya JG; Peterson DL; Ramanan D; Jain K; Eddy ML; Hornig M; Lipkin WI
Microbiome; 2017 Apr; 5(1):44. PubMed ID: 28441964
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
Maes M; Twisk FN; Ringel K
Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
Blomberg J; Rizwan M; Böhlin-Wiener A; Elfaitouri A; Julin P; Zachrisson O; Rosén A; Gottfries CG
Front Immunol; 2019; 10():1946. PubMed ID: 31475007
[TBL] [Abstract][Full Text] [Related]
6. Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin.
Maes M; Twisk FN; Kubera M; Ringel K
J Affect Disord; 2012 Feb; 136(3):933-9. PubMed ID: 21975140
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
de Vega WC; Herrera S; Vernon SD; McGowan PO
BMC Med Genomics; 2017 Feb; 10(1):11. PubMed ID: 28231836
[TBL] [Abstract][Full Text] [Related]
8. Serum Immune Proteins in Moderate and Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients.
Hardcastle SL; Brenu EW; Johnston S; Nguyen T; Huth T; Ramos S; Staines D; Marshall-Gradisnik S
Int J Med Sci; 2015; 12(10):764-72. PubMed ID: 26516304
[TBL] [Abstract][Full Text] [Related]
9. Impact of Long-Term Cryopreservation on Blood Immune Cell Markers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Biomarker Discovery.
Gómez-Mora E; Carrillo J; Urrea V; Rigau J; Alegre J; Cabrera C; Oltra E; Castro-Marrero J; Blanco J
Front Immunol; 2020; 11():582330. PubMed ID: 33329554
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
Hardcastle SL; Brenu EW; Johnston S; Nguyen T; Huth T; Ramos S; Staines D; Marshall-Gradisnik S
J Transl Med; 2015 Sep; 13():299. PubMed ID: 26370228
[TBL] [Abstract][Full Text] [Related]
11. In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation.
Maes M; Ringel K; Kubera M; Anderson G; Morris G; Galecki P; Geffard M
J Affect Disord; 2013 Sep; 150(2):223-30. PubMed ID: 23664637
[TBL] [Abstract][Full Text] [Related]
12. Frequent IgG subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome.
Guenther S; Loebel M; Mooslechner AA; Knops M; Hanitsch LG; Grabowski P; Wittke K; Meisel C; Unterwalder N; Volk HD; Scheibenbogen C
Hum Immunol; 2015 Oct; 76(10):729-35. PubMed ID: 26429318
[TBL] [Abstract][Full Text] [Related]
13. Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment.
Cabanas H; Muraki K; Eaton-Fitch N; Staines DR; Marshall-Gradisnik S
Front Immunol; 2021; 12():687806. PubMed ID: 34326841
[TBL] [Abstract][Full Text] [Related]
14. Bioenergetic and Proteomic Profiling of Immune Cells in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients: An Exploratory Study.
Fernandez-Guerra P; Gonzalez-Ebsen AC; Boonen SE; Courraud J; Gregersen N; Mehlsen J; Palmfeldt J; Olsen RKJ; Brinth LS
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209852
[TBL] [Abstract][Full Text] [Related]
15. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Where will the drugs come from?
Toogood PL; Clauw DJ; Phadke S; Hoffman D
Pharmacol Res; 2021 Mar; 165():105465. PubMed ID: 33529750
[TBL] [Abstract][Full Text] [Related]
16. Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study.
Lidbury BA; Kita B; Lewis DP; Hayward S; Ludlow H; Hedger MP; de Kretser DM
J Transl Med; 2017 Mar; 15(1):60. PubMed ID: 28302133
[TBL] [Abstract][Full Text] [Related]
17. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
Brenu EW; van Driel ML; Staines DR; Ashton KJ; Ramos SB; Keane J; Klimas NG; Marshall-Gradisnik SM
J Transl Med; 2011 May; 9():81. PubMed ID: 21619669
[TBL] [Abstract][Full Text] [Related]
18. Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study.
Unger ER; Lin JS; Tian H; Natelson BH; Lange G; Vu D; Blate M; Klimas NG; Balbin EG; Bateman L; Allen A; Lapp CW; Springs W; Kogelnik AM; Phan CC; Danver J; Podell RN; Fitzpatrick T; Peterson DL; Gottschalk CG; Rajeevan MS;
Am J Epidemiol; 2017 Apr; 185(8):617-626. PubMed ID: 28338983
[TBL] [Abstract][Full Text] [Related]
19. The role of low-grade inflammation in ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) - associations with symptoms.
Jonsjö MA; Olsson GL; Wicksell RK; Alving K; Holmström L; Andreasson A
Psychoneuroendocrinology; 2020 Mar; 113():104578. PubMed ID: 31901625
[TBL] [Abstract][Full Text] [Related]
20. Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natural Killer Cells From Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
Cabanas H; Muraki K; Staines D; Marshall-Gradisnik S
Front Immunol; 2019; 10():2545. PubMed ID: 31736966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
